Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
https://www.zacks.com/stock/news/2200712/reasons-to-retain-fresenius-medical-fms-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2200712
Dec 20, 2023 - Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
0
Reasons to Add Integer Holdings (ITGR) to Your Portfolio Now
https://www.zacks.com/stock/news/2200925/reasons-to-add-integer-holdings-itgr-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2200925
Dec 21, 2023 - Integer Holdings' (ITGR) research and product development activities and a solid foothold in the broader MedTech space raise optimism about the stock.
0
Here's Why You Should Retain Veeva Systems (VEEV) Stock Now
https://www.zacks.com/stock/news/2201457/here-s-why-you-should-retain-veeva-systems-veev-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2201457
Dec 22, 2023 - Veeva Systems' (VEEV) strong product portfolio raises optimism about the stock.
0
3 Reasons to Retain Nevro (NVRO) in Your Portfolio for Now
https://www.zacks.com/stock/news/2202284/3-reasons-to-retain-nevro-nvro-in-your-portfolio-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2202284
Dec 26, 2023 - Investors continue to be optimistic about Nevro (NVRO) due to its R&D edge.
0
Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now
https://www.zacks.com/stock/news/2205758/here-s-why-you-should-retain-myriad-genetics-mygn-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2205758
Jan 04, 2024 - Investors are optimistic about Myriad Genetics (MYGN) on robust testing volumes and strong solvency position.
0
Boston Scientific (BSX) Rides on Global Growth Amid Macro Woes
https://www.zacks.com/stock/news/2206372/boston-scientific-bsx-rides-on-global-growth-amid-macro-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2206372
Jan 05, 2024 - Within APAC, Boston Scientific (BSX) is registering strong growth in Japan and China.
0
Asensus Surgical (ASXC) Completes Surgeon Lab for LUNA
https://www.zacks.com/stock/news/2207066/asensus-surgical-asxc-completes-surgeon-lab-for-luna?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2207066
Jan 08, 2024 - Asensus Surgical's (ASXC) latest Surgeon Lab helps it move closer to a finalized LUNA product.
0
SenesTech's (SNES) New Partnership to Broaden Evolve's Scope
https://www.zacks.com/stock/news/2207539/senestech-s-snes-new-partnership-to-broaden-evolve-s-scope?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2207539
Jan 09, 2024 - The collaboration with a global leader in irrigation solutions for sustainable agriculture aligns with SenesTech's (SNES) target to introduce Evolve to a broader audience.
0
Here's Why You Should Retain Omnicell (OMCL) Stock Now
https://www.zacks.com/stock/news/2207629/here-s-why-you-should-retain-omnicell-omcl-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2207629
Jan 09, 2024 - Investors are optimistic about Omnicell (OMCL) owing to its strong Pharmacy model and geographical expansion.
0
Cardinal Health (CAH) Streamlines Operation With New Structure
https://www.zacks.com/stock/news/2208203/cardinal-health-cah-streamlines-operation-with-new-structure?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2208203
Jan 10, 2024 - Cardinal Health's (CAH) new reporting structure is likely to streamline operations, providing better visibility of growth areas. At-home solutions and OptiFreight Logistics are possibly the key value creators.
0